Advances in predicting patient survival in pulmonary sarcoidosis
| Autor: | Gamze Kirkil, Robert P. Baughman, Elyse E. Lower |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
business.industry Health Policy Pulmonary disease Patient survival medicine.disease Pulmonary hypertension 03 medical and health sciences 0302 clinical medicine Pulmonary sarcoidosis 030220 oncology & carcinogenesis Internal medicine Pulmonary fibrosis medicine Cardiology Pharmacology (medical) Sarcoidosis business Pharmacology Toxicology and Pharmaceutics (miscellaneous) 030217 neurology & neurosurgery |
| Zdroj: | Expert Opinion on Orphan Drugs. 9:113-122 |
| ISSN: | 2167-8707 |
| DOI: | 10.1080/21678707.2021.1925107 |
| Popis: | Introduction: Pulmonary disease remains the most common reason for death in sarcoidosis with pulmonary fibrosis and pulmonary hypertension the two most common causes of mortality. Although most sar... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|